Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit

Annals of Clinical and Laboratory Science

Volumn 43, Issue 4, 2013, Pages 429-435

  Pierce, Wesly ^a   Mazur, Joseph ^b   Greenberg, Charles ^b   Mueller, Joan ^c   Foster, Joyce ^c   Lazarchick, John ^c  

^a St Dominic Jackson Memorial Hospital   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticoagulants; Antithrombins; Cost control; Drug toxicity; Hospital; Intensive care units; Laboratories; Platelet factor 4; Thrombocytopenia

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4;

4TS SCORING SYSTEM; ADULT; ARTICLE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; SCORING SYSTEM; SEROTONIN RELEASE; THROMBOCYTE COUNT; CHEMICALLY INDUCED; DIAGNOSTIC USE; EVALUATION STUDY; METABOLISM; METHODOLOGY; RETROSPECTIVE STUDY; STANDARDS; THROMBOCYTOPENIA;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; INTENSIVE CARE UNITS; PLATELET COUNT; PLATELET FACTOR 4; RESEARCH DESIGN; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 84889045038     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia. American College of Chest Physicians evidence-based clinical practice guidelines, 8th ed. Chest 2008;133:340S-80.
2. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated heparin and low-molecularweight heparin thromboprophylaxis: A meta-analysis. Blood 2005;106:2710-2715.
3. Weismann RE, Tobin RW. Arterial embolism occurring during systemic heparin therapy. Arch Surg 1958;76:219-227.
4. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992;68:95-96.
5. Lo GK, Sigouin CS, Warkentin TE. What is the potential for over-diagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007;82:1037-1043.
6. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8.
7. Napolitano LM, Warkentin TE, AlMahameed A, Nasraway SA. Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management. Crit Care Med 2006;34(12):2898-2911.
8. Cuker A. Heparin-induced thrombocytopenia (HIT) in 2011: An epidemic of overdiagnosis. Thromb Haemost 2011;106:993-994.
9. Smythe MA, Warkenti TE, Woodhouse AL, Zakalik D. Venous limb gangrene and fatal hemorrhage: Adverse consequences of HIT "overdiagnosis"in a patient with antiphospholipid syndrome. Am J Hematol 2011;86:188-191.
10. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb and Haemost 2006;4:759-765.
11. Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T's score. J Thromb Haemost 2010;8(7):1483-1487.
12. Pouplard C, Gueret P, Fouassier M, et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin induced thrombocytopenia. J Thromb Haemost 2007;5:1373-1379.
13. Crowther MA, Cook DJ, Albert M, et al. The 4Ts scoring system for heparin-induced thrombocytopenia in medicalsurgical intensive care patients. J Crit Care 2010;25:287-293.
14. Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) Score: A novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010;8:2642-2650.
15. Strutt JK, Mackey JE, Johnson SM, Sylvia LM. Assessment of the 4Ts pretest clinical scoring system as a predictor of heparininduced thrombocytopenia. Pharmacotherapy 2011;31(2):138-145.
16. Ruf KM, Bensadoun ES, Davis GA, Flynn JD, Lewis DA. A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia. Thromb Haemost 2011;105:553-559.
17. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004;2:2133-2137.
18. Baughman RP, Lower EE, Flessa HG, et al. Thrombocytopenia in the intensive care unit. Chest 1993;104:1243-1241.
19. Vandershueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000;28:1871-1876.
20. Drews RE. Critical issues in hematology: Anemia, thrombocytopenia, coagulopathy and blood product transfusions in critically ill patients. Clin Chest Med 2003;24:607-622.
21. Warkentin TE, Robert RS, Hirsh J, et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003;163:2518-2524.
22. Verma AK, Levine M, Shalansky SJ, et al. Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 2003;23:745-753.
23. Wanat M, Fitousis K, Hall J, Rice L. PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit. Clin Appl Thromb Hemost 2012; [Epub ahead of print].
24. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004;2:2133-2137.
25. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008;100:678-684.